Literature DB >> 16426011

Multilocus sequence types, serotypes, and variants of the surface antigen PspA in Streptococcus pneumoniae isolates from meningitis patients in Poland.

Ewa Sadowy1, Anna Skoczyñska, Janusz Fiett, Marek Gniadkowski, Waleria Hryniewicz.   

Abstract

Meningitis caused by Streptococcus pneumoniae represents an important factor of morbidity and mortality in humans. In a significant number of cases, this disease is associated with specific clones of the organism, the so-called invasive pneumococcal clones. The aim of the study was to analyze 156 S. pneumoniae isolates identified as etiological agents of meningitis in Poland in the years 1997 through 2002. The isolates were characterized by multilocus sequence typing (MLST), and the results were compared with those obtained by pulsed-field gel electrophoresis (PFGE) and with the MLST data on invasive pneumococci from other countries. Eighty-nine different sequence types were found in the group of isolates, 50 of which had been known before including 19 of the major invasive clones. However, a significant fraction of the isolates possessed novel combinations of known and new MLST alleles. The majority of penicillin-nonsusceptible isolates belonged to the group of international multiresistant clones (Spain(23F)-1, Spain(6B)-2, Spain(9V)-3, Poland(23F)-16, and Poland(6B)-20), which underlined the importance of these in the dissemination of antimicrobial resistance. The results of the MLST analysis correlated well with the PFGE data, thus again demonstrating good congruence between the two typing methods for S. pneumoniae. The majority of the isolates (95.5%) belonged to families 1 or 2 of the surface protein PspA, confirming its potential usefulness as the vaccine antigen candidate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426011      PMCID: PMC1356625          DOI: 10.1128/CVI.13.1.139-144.2006

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  29 in total

1.  Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms.

Authors:  H Grundmann; S Hori; G Tanner
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.

Authors:  L McGee; L McDougal; J Zhou; B G Spratt; F C Tenover; R George; R Hakenbeck; W Hryniewicz; J C Lefévre; A Tomasz; K P Klugman
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

3.  Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential.

Authors:  Angela B Brueggemann; David T Griffiths; Emma Meats; Timothy Peto; Derrick W Crook; Brian G Spratt
Journal:  J Infect Dis       Date:  2003-04-04       Impact factor: 5.226

4.  Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae.

Authors:  S K Hollingshead; R Becker; D E Briles
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Characteristics of the major etiologic agents of bacterial meningitis isolated in Poland in 1997-1998.

Authors:  A Skoczyńska; P Kriz; H B Konradsen; W Hryniewicz
Journal:  Microb Drug Resist       Date:  2000       Impact factor: 3.431

6.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

Authors:  W P Hausdorff; J Bryant; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

7.  Meningitis in infancy in England and Wales: follow up at age 5 years.

Authors:  H Bedford; J de Louvois; S Halket; C Peckham; R Hurley; D Harvey
Journal:  BMJ       Date:  2001-09-08

8.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

9.  A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease.

Authors:  Mark C Enright; Brian G Spratt
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

10.  Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children.

Authors:  M C Vela Coral; N Fonseca; E Castañeda; J L Di Fabio; S K Hollingshead; D E Briles
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

View more
  10 in total

1.  Phenotypic and molecular analysis of penicillin-nonsusceptible Streptococcus pneumoniae isolates in Poland.

Authors:  Ewa Sadowy; Radoslaw Izdebski; Anna Skoczynska; Pawel Grzesiowski; Marek Gniadkowski; Waleria Hryniewicz
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

2.  Diversity of pneumococcal surface protein A (PspA) and relation to sequence typing in Streptococcus pneumoniae causing invasive disease in Chinese children.

Authors:  J Qian; K Yao; L Xue; G Xie; Y Zheng; C Wang; Y Shang; H Wang; L Wan; L Liu; C Li; W Ji; Y Wang; P Xu; S Yu; Y-W Tang; Y Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-04       Impact factor: 3.267

3.  The relBE2Spn toxin-antitoxin system of Streptococcus pneumoniae: role in antibiotic tolerance and functional conservation in clinical isolates.

Authors:  Concha Nieto; Ewa Sadowy; Adela G de la Campa; Waleria Hryniewicz; Manuel Espinosa
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

4.  An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa.

Authors:  Kedibone M Mothibeli; Mignon du Plessis; Anne von Gottberg; Linda de Gouveia; Peter Adrian; Shabir A Madhi; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

5.  Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae.

Authors:  Merit M Melin; Susan K Hollingshead; David E Briles; Mika I Lahdenkari; Terhi M Kilpi; Helena M Käyhty
Journal:  Clin Vaccine Immunol       Date:  2008-08-27

6.  Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers.

Authors:  Merit M Melin; Susan K Hollingshead; David E Briles; William P Hanage; Mika Lahdenkari; Tarja Kaijalainen; Terhi M Kilpi; Helena M Käyhty
Journal:  Clin Vaccine Immunol       Date:  2008-08-27

7.  A new variant of the capsule 3 cluster occurs in Streptococcus pneumoniae from deceased wild chimpanzees.

Authors:  Dalia Denapaite; Regine Hakenbeck
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

Review 8.  A Jack of All Trades: The Role of Pneumococcal Surface Protein A in the Pathogenesis of Streptococcus pneumoniae.

Authors:  Jessica R Lane; Muralidhar Tata; David E Briles; Carlos J Orihuela
Journal:  Front Cell Infect Microbiol       Date:  2022-02-02       Impact factor: 6.073

9.  PspA family distribution, antimicrobial resistance and serotype of Streptococcus pneumoniae isolated from upper respiratory tract infections in Japan.

Authors:  Muneki Hotomi; Akihisa Togawa; Masamitsu Kono; Yorihiko Ikeda; Shin Takei; Susan K Hollingshead; David E Briles; Kenji Suzuki; Noboru Yamanaka
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

10.  Diversity of pneumococcal surface protein A (PspA) among prevalent clones in Spain.

Authors:  Dora Rolo; Carmen Ardanuy; Ana Fleites; Rogelio Martín; Josefina Liñares
Journal:  BMC Microbiol       Date:  2009-05-06       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.